Effect of Mosapride citrate (cas 112885-42-4) Hydrate on the Colon Cleansing Action of Polyethylene Glycol Electrolyte Lavage Solution (PEG-ELS) in Guinea Pigs
-
Add time:08/04/2019 Source:sciencedirect.com
.Polyethylene glycol electrolyte lavage solution (PEG-ELS) is widely used for colon cleansing prior to colonoscopy and colonic surgery. It has recently been shown that coadministration of PEG-ELS and Mosapride citrate (cas 112885-42-4) hydrate (mosapride), a selective 5-HT4–receptor agonist, is clinically useful for barium enema examination as it allows adequate barium coating. However, there is no report showing that mosapride has beneficial effects on colon cleansing and its underlying mechanism in experimental animals. In the present study, we investigated the effects of mosapride on colonic transit and on the colon cleansing action of PEG-ELS in guinea pigs. Mosapride (10 – 20 mg/kg, i.g.) significantly enhanced colonic transit rate in guinea pigs. Although PEG-ELS alone showed adequate colon cleansing action, excess fluid remained in the colon. Coadministration of mosapride (20 mg/kg) and PEG-ELS, regardless of mosapride timing, reduced colonic content weight (dry residue and water amount) as compared to PEG-ELS alone. These findings suggest that mosapride enhances the colon cleansing action of PEG-ELS via an increase in colonic transit in guinea pigs, that is, it reduces not only fecal residue but also excessive fluid in the colonic lumen. It is therefore believed that coadministration of mosapride and PEG-ELS can allow better visualization in barium enema examination.
We also recommend Trading Suppliers and Manufacturers of Mosapride citrate (cas 112885-42-4). Pls Click Website Link as below: cas 112885-42-4 suppliers
Prev:Liquid chromatography–tandem mass spectrometric method for determination of Mosapride citrate (cas 112885-42-4) in equine tissues
Next:Copper(I)-catalyzed coupling reaction of aryl boronic acids with N,O-acetals and N,N-aminals under atmosphere leading to α-aryl glycine derivatives and diarylmethylamine derivatives) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Liquid chromatography–tandem mass spectrometric method for determination of Mosapride citrate (cas 112885-42-4) in equine tissues08/03/2019
- Effects of Mosapride citrate (cas 112885-42-4), a 5-HT4–Receptor Agonist, on Gastric Distension–Induced Visceromotor Response in Conscious Rats08/02/2019
- Dual Role of Mosapride citrate (cas 112885-42-4) Hydrate on the Gastric Emptying Evaluated by the Breath Test in Conscious Rats08/01/2019
- Development of a novel combination tablet containing trimebutine maleate and Mosapride citrate (cas 112885-42-4) for the treatment of functional dyspepsia07/31/2019
- Spectrophotometric determination of carbamazepine and Mosapride citrate (cas 112885-42-4) in pure and pharmaceutical preparations07/30/2019
- Dose-dependent effects of Mosapride citrate (cas 112885-42-4) on duodenal and cecal motility in donkeys (Equus asinus)07/29/2019
- The effect of Mosapride citrate (cas 112885-42-4) on constipation in patients with diabetes07/28/2019
- Comparison of the effects of esomeprazole plus Mosapride citrate (cas 112885-42-4) and botulinum toxin A on vocal process granuloma07/27/2019
- Molecularly imprinted polymers based biomimetic sensors for Mosapride citrate (cas 112885-42-4) detection in biological fluids07/26/2019
-
Health and Chemical more >
-
Related Products